We have observed
9 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after November 20, 2014).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
NOVEL ANTIBODY FORMAT
IMPROVED METHOD FOR SELECTING POLYPEPTIDE PRODUCING CELLS
COMPLEMENT FACTOR BASED AFFINITY CHROMATOGRAPHY
SPR-BASED DUAL-BINDING ASSAY FOR THE FUNCTIONAL ANALYSIS OF MULTISPECIFIC MOLECULES
METHOD TO ANALYZE AND OPTIMIZE GENE EDITING MODULES AND DELIVERY APPROACHES
IN VITRO GLYCOENGINEERING OF ANTIBODIES
RE-USE OF ENZYMES IN IN VITRO GLYCOENGINEERING OF ANTIBODIES
METHOD FOR IN VITRO GLYCOENGINEERING OF ANTIBODIES
B-CELL CULTIVATION METHOD